Abbott GMP Investments “Pay Off” In Pharma, Despite Diagnostics Setback

Abbott's efforts to address quality control issues in the diagnostics division have had a beneficial effect on the company's GMP compliance status in pharmaceuticals, the company told a June 11 conference call